期刊文献+

甘精胰岛素联合阿卡波糖治疗继发失效糖尿病 被引量:2

Clinical Observation of Insulin Glargine Combined with Acarbose on Treatment of Type 2 Diabetes Mellitus with Secondary Failure
下载PDF
导出
摘要 目的:观察甘精胰岛素联合阿卡波糖治疗继发失效2型糖尿病的疗效。方法:将62例2型糖尿病患者分为2组,治疗组应用甘精胰岛素联合阿卡波糖;对照组应用诺和灵30R联合二甲双胍治疗,比较两组治疗后的血糖和HbAlc以及胰岛素用量。结果:治疗组治疗后血糖和HbAlc水平均低于对照组(P<0.05),且胰岛素用量更少(P<0.01)。结论:甘精胰岛素联合阿卡波糖治疗能很好地控制继发失效2型糖尿患者的血糖。 Objective: To observe the effects of insulin glargine combined with acarbose on treafment of type 2 diabetes mellitus with secondary, failure. Method : Sixty-two patients of type 2 diabetes mellitus with secondary failure were divided into two groups : the treatment group treated with insulin glargine combined with acarbose, and the control group treated with premixed insulin 30R( Novolin 30R) combined with mefformin. Fasting blood glucose, 2 h blood glucose, glyeosylate hemoglobin( HbAle), the dose of insulin were measured and compared before and after treatment. Result : The level of blood glucose and HbA1 c in the treatment group was lower than the control group( P 〈 0.05 ), and the dose of insulin was less in the treatment group than the control group (P 〈 0.01 ). Conclusion: The treatments of insulin glargine combined with acarbose can control blood glucose in type 2 diabetes mellitus with secondary failure effectively.
出处 《中国药师》 CAS 2008年第11期1354-1355,共2页 China Pharmacist
关键词 甘精胰岛素 阿卡波糖 2型糖尿病 继发失效 Insulin glargine Acarbose Type 2 diabetes mellitus Secondary failure
  • 相关文献

参考文献6

二级参考文献35

  • 1程桦,傅祖植,李焱,陈劲松,陆祖谦,黄仕泽,钟光恕,陈玉驹,严棠.四项基本临床试验在非胰岛素依赖型糖尿病优降糖继发失效时的应用[J].中国糖尿病杂志,1994,2(3):130-133. 被引量:24
  • 2周健,喻明,贾伟平,李青,李鸣,马晓静,陆蔚,项坤三.应用动态血糖监测系统评估2型糖尿病患者日内及日间血糖波动幅度[J].中华内分泌代谢杂志,2006,22(3):286-288. 被引量:177
  • 3中华人民共和国卫生部.新药临床研究指导原则[S]:第一辑[Z].,1993.82-85.
  • 4Purrello F, Rabuazza AM. Metabolic factors that affect betacell function and survival. Diabet Nutr Metab, 2000, 13: 84-91.
  • 5Sivitz WI. Lipotoxieity and glueotoxieity in type 2 diabetes. Effects on development and progression. Postgrad Med, 2001,109: 55-59,63-64.
  • 6Lenhard M J, Reeves GD. Continous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med,2001,161: 2293-2300.
  • 7Dupuy O, Mayaudon H, Palou M, et al. Optimized transient insulin infusion in uneontrolled type 2 Diabetes : Evaluation of a pragmatie attitude. Diabet Med, 2000,26 : 371-375.
  • 8Valensi P, Moura I, Magoarou M,et al. Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment. Diabet Metab,1997,23: 51-57.
  • 9Lormeau B, Aurousseau MH, Valensi P, et al. Hyperinsulinemia and hypofibrinolysis: effects of short-term optimized glyeemic control with contineuous insulin infusion in type Ⅱ diabetie patients. Metabolism,1997,46: 1074-1079.
  • 10Ilkova H, Glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.

共引文献890

同被引文献31

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部